Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Dehay, Benjamin ^a,b   Dalkara, Deniz ^c   Dovero, Sandra ^a,b   Li, Qin ^d   Bezard, Erwan ^a,b,d  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^c University of California   (United States)

^d INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; BRAIN; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; NEWBORN; RHESUS MONKEY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, NEWBORN; BRAIN; DEPENDOVIRUS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MACACA MULATTA; TRANSDUCTION, GENETIC;

EID: 84859743388     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00253     Document Type: Article

References (15)

1. Chan, A. W., Chong, K. Y., Martinovich, C., Simerly, C. & Schatten, G. Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 291, 309-312 (2001). (Pubitemid 32096317)
2. Yang, S. H. et al. Towards a transgenic model of Huntington's disease in a nonhuman primate. Nature 453, 921-924 (2008).
3. Bowers, W. J., Breakefield, X. O. & Sena-Esteves, M. Genetic therapy for the nervous system. Hum Mol Genet 20, R28-41 (2011).
4. Foust, K. D. et al. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27, 59-65 (2009).
5. Zhang, H. et al. Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther 19, 1440-1448 (2011).
6. Cearley, C. N. & Wolfe, J. H. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther 13, 528-537 (2006). (Pubitemid 43257620)
7. Duque, S. et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther 17, 1187-1196 (2009).
8. Foust, K. D. et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28, 271-274 (2010).
9. Dominguez, E. et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20, 681-693 (2011).
10. Spampanato, C. et al. Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder. Mol Ther 19, 860-869 (2011).
11. Kamiya, A. Animal models for schizophrenia via in utero gene transfer: understanding roles for genetic susceptibility factors in brain development. Prog Brain Res 179, 9-15 (2009).
12. Rahim, A. A. et al. Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system. FASEB J 25, 3505-3518 (2011).
13. Gray, S. J. et al. Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).Mol Ther 18, 570-578 (2010).
14. Maheshri, N., Koerber, J. T., Kaspar, B. K. & Schaffer, D. V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat Biotechnol 24, 198-204 (2006). (Pubitemid 43221704)
15. Fasano, S. et al. Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proc Natl Acad Sci USA 107, 21824-21829 (2010).